Volume 131, Issue 6, Pages (December 2006)

Slides:



Advertisements
Similar presentations
Volume 141, Issue 2, Pages e2 (August 2011)
Advertisements

Volume 132, Issue 3, Pages (March 2007)
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 144, Issue 3, Pages e1 (March 2013)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 134, Issue 7, Pages (June 2008)
Volume 33, Issue 3, Pages (September 2010)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
Volume 137, Issue 3, Pages (September 2009)
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 143, Issue 5, Pages (November 2012)
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 141, Issue 1, Pages e2 (July 2011)
Following the Development of a CD4 T Cell Response In Vivo
Volume 135, Issue 6, Pages (December 2008)
by Norman Nausch, Ioanna E
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 140, Issue 7, Pages (June 2011)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 143, Issue 5, Pages e4 (November 2012)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Volume 132, Issue 7, Pages (June 2007)
Volume 10, Issue 1, Pages (January 2015)
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 141, Issue 3, Pages (September 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 135, Issue 3, Pages e5 (September 2008)
Volume 18, Issue 5, Pages (May 2003)
Volume 140, Issue 7, Pages (June 2011)
Volume 135, Issue 3, Pages (September 2008)
Volume 140, Issue 1, Pages e3 (January 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 140, Issue 5, Pages e3 (May 2011)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 143, Issue 1, Pages (July 2012)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 134, Issue 7, Pages (June 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 144, Issue 3, Pages e1 (March 2013)
Volume 33, Issue 3, Pages (September 2010)
Volume 132, Issue 1, Pages (January 2007)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 135, Issue 1, Pages (July 2008)
Volume 33, Issue 5, Pages (November 2010)
Volume 28, Issue 6, Pages (June 2008)
Volume 135, Issue 5, Pages e5 (November 2008)
Volume 135, Issue 2, Pages e2 (August 2008)
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells  Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.
Volume 135, Issue 3, Pages (September 2008)
Volume 140, Issue 1, Pages (January 2011)
Volume 17, Issue 2, Pages (February 2009)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 143, Issue 2, Pages (August 2012)
Volume 31, Issue 4, Pages (October 2009)
Volume 126, Issue 6, Pages (September 2006)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 28, Issue 5, Pages (May 2008)
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 20, Issue 6, Pages (June 2004)
Presentation transcript:

Volume 131, Issue 6, Pages 1775-1785 (December 2006) CD8+CD28− Regulatory T Lymphocytes Prevent Experimental Inflammatory Bowel Disease in Mice  Ingrid MÉnager–Marcq, CÉline PomiÉ, Paola Romagnoli, Joost P.M. van Meerwijk  Gastroenterology  Volume 131, Issue 6, Pages 1775-1785 (December 2006) DOI: 10.1053/j.gastro.2006.09.008 Copyright © 2006 AGA Institute Terms and Conditions

Figure 1 Phenotypic analysis of CD8+CD28− splenocytes. (A) C57BL/6 splenocytes were analyzed for expression of CD4, CD8, and CD28 by flow cytometry. CD28 expression by CD4+ cells (thick gray line) and CD8+ cells (thick black line) is shown. Thin lines represent background signal on CD8+ (black) and CD4+ (gray) splenocytes as determined with an isotype-matched control antibody. (B) Expression of indicated surface markers by electronically gated CD8+CD28− cells (thick gray line, gray shaded) and CD8+CD28+ cells (thick black line). Thin lines indicate background staining on CD8+CD28− cells (gray) and CD8+CD28+ cells (black). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 2 Freshly isolated CD8+CD28− regulatory T cells inhibit proliferation and IFN-γ production by CD4+ responder T cells. (A) CD28− and CD28+ CD8+ cells were sorted by flow cytometry as described in Materials and Methods. (B) Indicated cells were cocultured, and proliferation was determined by measuring incorporation of 3H-thymidine. (C) DBA/2 APCs were cultured with 105 C57BL/6 CD4+ and increasing numbers of CD8+CD28+ splenocytes (at indicated ratios), and proliferation was determined by measuring incorporation of 3H-thymidine. Dashed line indicates background proliferation in the presence of MHC-deficient APCs. (D) Indicated cells were cocultured; after 3 days, cells were analyzed for expression of CD4 and production of IFN-γ by flow cytometry. Indicated numbers represent percentages of IFN-γ–producing cells among CD4+ cells. The results shown are representative of those obtained in 3 independent experiments. Indicated are mean values ± SD (triplicates); ***P < .001 (Student t test). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 3 CD8+CD28− regulatory T cells express IL-10 and TGF-β1, but these cytokines are not required for their suppressive activity in vitro. (A) Sorted CD8+CD28− splenocytes were activated in vitro with anti-CD3ϵ antibody during 1 week and then stained with antibodies specific for IL-10 or pro–TGF-β1 derived LAP (gray line with gray shading) or with isotype-matched control antibodies (black line without shading). (B) Indicated responder CD4+ T cells were cultured in the presence of indicated CD8+CD28− suppressor cells and anti-CD3ϵ antibody. Proliferation in the cultures was determined by assessment of 3H-thymidine incorporation. The results shown are representative of those obtained in 2 independent experiments. Indicated are mean values ± SD (triplicates); ***P < .001 (Student t test). T-cell proliferation was less efficiently inhibited by IL-10–deficient than by wild-type CD8+CD28− cells (P < .05, Student t test). DnTβRII responders were less efficiently inhibited than wild-type responders by CD8+CD28− cells (P < .05, Student t test). (C) As in B, but responder cells were CFSE labeled before culture and proliferation was assessed by fluorescence-activated cell sorter analysis of CFSE dilution on electronically gated CD4+ responders. The dashed reference line is to indicate CFSE signal on undivided cells. Shown are representative results from 2 independent experiments. Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 4 CD8+CD28− regulatory T cells prevent development of colitis. RAG-2–deficient C57BL/6 mice were injected with indicated cells. (A) Evolution of weight of animals. Shown is the mean weight ± SD (n = 4 from one representative experiment out of 3) as a percentage of weight at the start of the experiment; *P < .05 (Mann–Whitney test). (B) Mice were killed 6 weeks after injection of T cells. Microscopic sections of distal colon were stained with H&E and examined for signs of colitis. The results shown are representative of those obtained in 3 independent experiments. (C) Colons of mice were examined as in B and clinical scores of colitis attributed as described in Materials and Methods (n = 12 from 3 independent experiments). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 5 IL-10 production by CD8+CD28− regulatory T cells is required for prevention of colitis. RAG-2–deficient C57BL/6 mice were injected with indicated cells. (A) Evolution of weight of animals. Shown is the mean weight ± SD (n = 4 from one representative experiment out of 3) as a percentage of weight at the start of the experiment; *P < .05 (Mann–Whitney test). (B) Mice were killed 6 weeks after injection of T cells. Microscopic sections of distal colon were stained with H&E and examined for signs of colitis. The results shown are representative of those obtained in 3 independent experiments. (C) Colons of mice were examined as in B and clinical scores of colitis attributed as described in Materials and Methods (n = 12 from 3 independent experiments). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 6 CD8+CD28− regulatory T cells do not prevent colitis induced with CD4+CD45RBhigh cells incapable of responding to TGF-β. RAG-2–deficient C57BL/6 mice were injected with indicated cells. (A) Evolution of weight of animals. Shown is the mean value ± SD (n = 5) as a percentage of weight at the start of the experiment; *P < .05 (Mann–Whitney test). Data from one representative experiment out of 3 are depicted. (B) Mice were killed 6 weeks after injection of T cells. Microscopic sections of distal colon were stained with H&E and examined for signs of colitis. The results shown are representative of those obtained in 2 independent experiments. (C) Colons of mice were examined as in B and clinical scores of colitis attributed as described in Materials and Methods (n = 11 from 2 independent experiments). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions

Figure 7 CD8+CD28− (but not CD8+CD28+) IELs and LPLs efficiently prevent development of colitis. (A) CD28 expression by (gray shading) or background staining on (black line) electronically gated CD8+TCRβ+ cells. RAG-2–deficient C57BL/6 mice were injected with indicated populations. (B) Evolution of weight of animals. Shown is the mean weight ± SD (n = 7 from 3 independent experiments) as a percentage of weight at the start of the experiment; *P < .05 (Mann–Whitney test). (C) Mice were killed 6 weeks after injection of T cells. Microscopic sections of distal colon were stained with H&E and examined for signs of colitis. The results shown are representative of those obtained in 3 independent experiments. (D) Colons of mice were examined as in C and clinical scores of colitis attributed as described in Materials and Methods (n = 7 from 3 independent experiments). Gastroenterology 2006 131, 1775-1785DOI: (10.1053/j.gastro.2006.09.008) Copyright © 2006 AGA Institute Terms and Conditions